Abstract: Human beings are exposed to many reactive electrophiles, both formed endogenously and from exogenous exposures. Such compounds could react with cellular biomolecules and form stable reaction products, adducts, at nucleophilic sites in proteins and DNA, constituting a risk for toxic effects. Adductomic approaches aim to study the totality of adducts, to specific biomolecules, by mass spectrometric screening. This Mini-Review focuses on the development and application of an adductomic approach for the screening of unknown adducts to N-terminal valine (Val) in haemoglobin (Hb) by liquid chromatography tandem mass spectrometry (LC-MS/MS). The approach is based on the FIRE procedure, a modified Edman procedure for the analysis of adducts to N-terminal Val in Hb by LC-MS/MS. In the first application of the approach, samples from 12 smokers/ non-smokers were screened for Hb adducts, and six previously identified adducts and 20 unknown adducts were detected. To confirm the observation of the detected unknown adducts, targeted screenings were performed in larger sets of blood samples (n = 50-120) from human cohorts. The majority of the previously detected unknown adducts was found in all analysed samples, with large interindividual variations in adduct levels. For structural identification of unknown adducts, a strategy using adductome LC-MS/MS data was formulated and applied. Six identified adducts correspond to ethylation and the precursor electrophiles ethyl vinyl ketone, glyoxal, methylglyoxal, acrylic acid and 1-octen-3-one. The observation of these adducts in human blood motivate further studies to evaluate possible contributions to health risks, as well as their potential as biomarkers of exposure.
Although much research during the last decades has concerned genetic and hereditary factors contributing to cancer and other chronic diseases, there is now increasing evidence that nongenetic factors are more important with regard to risk for disease development [1] [2] [3] . Human beings are constantly exposed to a broad range of chemical compounds from different sources and to a large extent these compounds are unknown. The concept of the exposome was introduced to describe the totality of exposures received by a person throughout life, from conception and onwards, including both endogenous and exogenous sources [4] . To disclose chemical compounds of importance as risk factors for chronic diseases, we need to be able to detect and identify unknown compounds in ongoing exposures. The assessment of the exposome is thus highly challenging and will require several techniques and methodologies, especially untargeted approaches for detection of unknown compounds.
Electrophilic compounds are considered important constituents of the exposome because of their ability to react and form covalently bound modifications at nucleophilic sites within DNA and proteins. Such modifications are called adducts. The totality of adducts to biomacromolecules is defined as the adductome [5] . The purpose of this Mini-Review was to discuss the concept and potential of adductomics as a tool for identification of chemical risk factors of chronic disease present in the exposure to the general population. Results from our adductomic studies of haemoglobin (Hb) adducts form a basis for the discussion. The key concepts of adductomics are discussed and exemplified, from screening to identification of detected unknown adducts as well as the following evaluation.
Formation of Adducts from Electrophiles In Vivo
Human beings are constantly exposed to reactive compounds, and this exposure is to a large extent unavoidable. The exposure is both of endogenous origin (e.g. from lipid peroxidation and oxidative stress) and from exogenous sources (as food and air pollution). Many compounds are not electrophilic upon exposure but are metabolically activated to electrophilic species (as epoxidation of alkenes by cytochrome P450 2E1). The formation of adducts from such compounds at nucleophilic sites in biomacromolecules may constitute risks of toxic effects. Electrophilic compounds could form adducts at nucleophilic sites in DNA if the reactivity or structure of the electrophiles favours such reactions. DNA adducts pose a risk of mutations if not repaired correctly, and might ultimately lead to cancer. Electrophiles can also react and form adducts with proteins and other biomolecules. The formation of protein adducts indicates that the same reactions are plausible with DNA, but not necessarily as the reactivity of electrophiles towards sites in DNA and proteins can differ considerably. Protein adducts may be associated with other toxic effects, for instance related to ageing processes.
Reactive compounds involved in adduct formation can be categorized in groups based on their reactive functional groups and mechanisms of adduct formation [6, 7] . Of special importance for this Mini-Review are epoxides that form adducts through nucleophilic substitution (S N 2-type mechanism); a, bunsaturated carbonyl compounds that form adducts through Michael addition; and aldehydes that form Schiff base-type adducts via carbinolamine intermediates. Other reactive species may react according to other patterns, such as nitrosamines through S N 1-type mechanisms. Examples of compounds from these groups are shown in table 1.
The extent of adduct formation depends on the reactivity of the electrophile, nucleophilicity and pK a of the nucleophilic atom, and steric factors [7] . Functional groups with a high degree of deprotonation at the physiological pH (pH 7.4) are more favourable for adduct formation compared to protonated functional groups. For many electrophiles, the major sites in proteins for adduct formation are the sulphur of the cysteine thiol, the nitrogens of the histidine imidazole and the NH 2 -group of N-terminal amino acids [7] . In DNA, sites for adduct formation include N7-guanine, O 6 -guanine and N3-adenine, etc. [8] .
Electrophiles typically have short half-lives in vivo due to their inherent reactivity and detoxification, through chemical and enzyme-mediated reactions. Electrophiles could thus not conveniently be measured as free compounds in vivo. However, the corresponding adducts to DNA and proteins are more stable and can be measured for quantification of internal exposure/dose. Adducts are often measured to DNA or the proteins haemoglobin (Hb) and human serum albumin (HSA), which are highly abundant in blood. Adducts to Hb and HSA have relatively long half-lives and are not repaired as DNA adducts.
Protein adducts thus accumulate over long periods (weeksmonths) after repeated exposures and can be used to quantify internal doses (in the meaning concentration over time) of electrophiles [7] .
Mass Spectrometry for Adduct Measurements
With regard to carcinogenic compounds, the first methods for adduct measurements were developed in the 1970s. Early studies concerned monitoring of protein adducts from, for example, ethylene oxide in occupational exposures [9] . During the 40-plus years of research regarding protein adducts, mass spectrometry (MS) has been the method of choice for their detection. Measurements by MS provide selectivity, as well as some structural information, and also enable reliable quantitative measurements using stable isotope-substituted internal standards. For a long time, gas chromatography-mass spectrometry (GC-MS) was the most used technique for protein adduct measurements. Sensitive GC-MS methods for several types and classes of adducts are available [7, 10] . Currently, most applications for protein adduct measurements utilize liquid chromatography tandem mass spectrometry (LC-MS/MS) which is more versatile compared to GC-MS. The main scanning modes for MS/MS and their uses and benefits are briefly described in table 2. In more recent studies, high-resolution MS (HRMS) has been used for measurement of adducts. HRMS measures ions with high accuracy which is useful for proposing elemental compositions of analytes. Some high-resolution instruments offer several different modes of MS/MS scanning, for example data-dependent acquisition, not available on triple quadrupole instruments (table 2) . 
For the measurement of DNA adducts, LC-MS/MS has been increasingly used during the last decade and is now the dominating technique. Because of the thermal instability and low volatility of many DNA adducts, GC-MS is seldom used for their assessment. Prior to the development of sensitive LC-MS/MS methods, the 32 P-post-labelling method was the most frequently used method for measurements of DNA adducts [11] .
Adductomics
Prior to the development of adductomic approaches, most methods for adduct measurements were targeted approaches, aiming at determination of single or a few specific adducts from specific exposures. The observation of background levels of several adducts to Hb and HSA in non-exposed control individuals, mainly by MS-based methodologies [7, 10] , demonstrated that adduct measurements may be used to detect exposures to electrophiles in individuals in the general population [7] . This has stimulated the interest to characterize the totality of adducts which could be detected in human blood samples. The aim of adductomics is to screen for all adducts simultaneously [5] and thereby detect previously unknown adducts of importance for, for example, chronic diseases. Adductomic methods may be used to study adduct patterns of different populations, which represent different exposure situations or diseases. This type of studies could provide valuable observations not obtained with targeted approaches. Adductomic approaches could also be used for untargeted screening of adducts from reactive metabolites, thereby being a valuable complement in metabolomic studies. The sources of most adducts detected through adductomics are unknown, and many modifications previously not considered in an 'adduct context', such as post-translational modifications and advance glycation end products, have to be considered in the evaluation of adductome data.
The term 'adductome' was first used by Kanaly et al. [12] , in their pioneering work regarding screening of DNA adducts in human lung tissue by LC-MS/MS. The screening was achieved by monitoring the loss of deoxyribose from nucleobases in the multiple reaction monitoring (MRM) mode. More than 700 possible DNA adducts were detected, clearly demonstrating the potential of this adductomic approach. This group has continued its work on DNA adductomics, studied lipid peroxidation-induced adducts [13] and performed intertissue comparisons of adduct patterns [14] in human samples.
The first publication on protein adductomics, by Li et al. [15] , concerned the screening of cysteine adducts (Cys34) in HSA. Tryptic peptides containing the modified Cys34 were enriched and screened by MS/MS in the MRM mode, monitoring four common fragments for each potential adduct. An average of about 70 possible adducts was detected in six pooled samples of HSA (from a total of 30 individuals). This group has continued their work on HSA adductomics and recently published an updated method for screening of Cys34 adducts using HRMS [16] .
Although the general concepts are the same, the field of adductomics may be divided into DNA adductomics and protein adductomics. For DNA adductomics, there is a thorough review published in 2014 by Balbo et al. [17] which covers all key aspects of the current screening methodologies. For protein adductomics, there is a review published in 2012 by Rappaport et al. [5] which discusses the potential applications of adductomics. Even though DNA adducts in general are more interesting with regard to genotoxic damage, it can be argued that protein adducts could be more useful for adductomic studies. Due to the accumulation of stable protein adducts from continuous backgrounds exposures, a larger number of unknown adducts are expected to be observed by protein adductomics [5, 7] .
The field of adductomics is still in an early phase and most published work concerns method development. A summary of adductomic studies of human samples published to date is given in table 3.
Mass Spectrometry for Adductomics
A successful MS screening of unknown adducts requires that the analytes of interest exhibit similar behaviours in the MS 
Tandem MS (MS/MS)
Product ion scan Fragmentation of a specific precursor ion to obtain its fragmentation pattern Neutral loss scan A specific offset (m/z) between precursor ions and fragments is scanned. Useful for screening of compounds of the same class Selected reaction monitoring (SRM)
A specific fragment of a specific precursor ion is scanned. Selective analysis, often used for quantification Multiple reaction monitoring (MRM)
Multiple SRMs in the same experiment (used to determine several analytes in the same experiment) Data-dependent acquisition Multiple precursor ions are selected for product ion scans based on set criteria (e.g. abundance).
Requires certain instruments, for example Orbitrap-type MS Data-independent acquisition All ions within a selected m/z range are subjected to product ion scans. Requires certain instruments, for example Orbitrap-type MS analysis, such as common fragmentation pathways in MS/MS. Such common properties are often first observed in the development of general analytical (targeted) procedures and could then be applied for untargeted screening procedures. All published methodologies for adductomics use LC-MS/MS to monitor fragmentation pathways common for all analytes of interest, for instance the neutral loss of the deoxyribose group (116 Da) in the screening of DNA adducts [17] . Many reported methods for adduct screening use methods of sequential lists of multiple reaction monitoring (MRM) transitions set-up similar to constant neutral loss scans [12, 15] . Discrete MRM transitions separated by a fixed m/z are used. Compared to full scan experiments, this increases the duty cycle and signal intensity for each analyte in the mass spectrometric run and make data interpretation more straightforward. To cover wide m/z ranges, multiple injections are often performed. This means that the cumulative time of analysis for each sample will be relatively long and susceptible to instrumental variations, which accentuates the use of suitable internal standards.
Recently, HRMS has been used for adductomic experiments [18] [19] [20] . HRMS has the ability to resolve isotopic peaks of ions and measure their masses with high accuracy. Accurate mass data can be used to propose elemental compositions of analytes, which may aid in the identification of detected unknowns. For instance, the identities of several unknown Cys34 adducts have been suggested from accurate masses [16, 19] . It should, however, be stressed that complementary approaches are needed for identification of most adducts. Even for adducts of low-molecular weights, there may be several structural isomers that could not be elucidated from accurate mass data. One example is the Hb adducts from methylglyoxal and acrylic acid (1-carboxyethyl and 2-carboxyethyl, respectively) that have the same elemental composition, but may be distinguished based on differing retention times and mass spectra [21] . Reference substances are essential for such purposes.
Adductomic Screening of Hb Adducts
In the last few years, we have developed and applied an adductomic method for screening of Hb adducts [22] . The method is based on the previously reported FIRE procedure for the analysis of adducts to N-terminal valine (Val) in Hb by LC-MS/MS [23, 24] . An Edman reagent, fluorescein isothiocyanate (FITC), is added to whole blood/lysate, and the N-terminal Hb adducts are derivatized and detached as adduct derivatives, fluorescein thiohydantoins (FTHs) ( fig. 1 ). Internal standards (FTH derivatives of deuterium-substituted Val adducts) are then added to the samples, which are subsequently purified using solid-phase extraction columns. The samples are analysed using LC-MS/MS in the MRM mode, with positive ionization. The estimated limit of detection for most of the detected adducts is 5 pmol/g Hb and the limit of quantification 15 pmol/g Hb (corresponding to approx. 0.03 pmol and 0.1 pmol injected on column, respectively). Internal standard calibration is used for quantification, and the adduct levels are adjusted for the Hb concentrations in the blood samples.
The FIRE procedure is applicable to modifications from a broad range of electrophiles, including epoxides (such as ethylene oxide) and a, b-unsaturated carbonyl compounds (such as acrylamide). The method has shown high detectability and high reproducibility. One limitation is, however, that when the N-terminal is blocked for reaction with the Edman reagent, with no free electron pair at the N-terminal nitrogen, it cannot be detached. This means that only mono-substituted N-terminal amino acids can be derivatized and detached. The method does not work for ring-closed adducts such as the N,N-(2,3-dihydroxy-1,4-butadiyl) Val adduct from diepoxybutane [25] . pancreas, spleen, kidney, heart, small intestine, total n = 68)
Screening of unknowns, focus on lipid peroxidation-induced adducts Chou et al. [55] Gastric mucosa (n = 2, pooled samples) Screening of unknowns, lipid peroxidation-induced adducts, screening followed by targeted analyses of individual samples Matsuda et al. [13] Colon tumours (human beings) (n = 10) Method development, database construction, screening, HRMS Hemeryck et al. [20] Protein adductomics Plasma (n = 6, pooled samples from 30 individuals)
HSA adducts. Method development, screening of unknowns Li et al. [15] Plasma (n = 3) HSA adducts. The detachment of N-substituted N-terminal Val in Hb during the neutral reaction conditions is highly favoured over the detachment of non-substituted Val due to a gem-dialkyl effect, giving effective enrichment of Edman derivatives of adducts ( fig. 2 ) [26] . The FIRE procedure is a further development of the previous N-alkyl Edman procedure, in which the reagent pentafluorophenyl isothiocyanate is used to detach N-terminal Hb adducts with subsequent determination using GC-MS [27] . This methodology has been applied in a large number of studies (in part reviewed by T€ ornqvist et al. [7] ). The FIRE procedure was primarily developed as a semi-high throughput alternative to that method. Because the analysis is carried out using LC-MS, the methodology is applicable to thermolabile, hydrophilic and non-volatile compounds, in comparison with the GC-MS method, making it suitable for adductomics. Prior to the adductomic screening, six known adducts had previously been studied in human blood samples using the FIRE procedure. Of these six, the adduct corresponding to methylation of the N-terminal is the most abundant. The major source to this adduct is the endogenous methylator S-adenosyl methionine (SAM) [28, 29] . The adduct from ethylene oxide was the first well-studied 'background' adduct, with endogenous formation of ethene/ethylene oxide shown to be the main source in the general population [30] , and with increased adduct levels in smokers due to the high levels of ethene in cigarette smoke [31] . Ethylene oxide is classified as a Group 1 carcinogen (carcinogenic to human beings) by the International Agency for Research on Cancer (IARC). The adducts from acrylamide (an IARC Group 2A carcinogen, i.e. a probable human carcinogen) and its metabolite glycidamide (genotoxic and carcinogenic) originate from the general exposure to acrylamide from food [32, 33] . The adduct from acrylonitrile (an IARC Group 2B carcinogen, i.e. possibly carcinogenic to human beings) is mainly observed in smokers, due to the presence of this compound in cigarette smoke [34] . The adduct corresponding to methyl vinyl ketone, observed at relatively high levels in most analysed blood samples, is thought to originate from endogenous formation and/or food [35] .
Development of the Adductomic Approach for Screening of N-terminal Hb Adducts.
During the development of the FIRE procedure, it was observed that N-terminal Val adducts studied as FTH derivatives exhibit similar fragmentation pathways, resulting in at least three common fragments ( fig. 1) . The general fragmentation of FTH derivatives was used to set up methods for adduct screening. To qualify as an adduct candidate, a compound should exhibit at least two of these fragments. The inclusion of several fragments is required for obtaining sufficient selectivity as interfering ions of the same m/z may be present, occasionally at relatively high concentrations. The presence of interferences is mainly due to the formation of by-products in the derivatization reaction (from the reagent, FITC).
In the first application of the method, twelve human blood samples (six from non-smokers and six from smokers) were used for adductomic screening of Hb adducts as FTH derivatives [22] . A range of 135 m/z (m/z 503-638) was screened. The range was selected so that all Hb adducts previously studied using modified Edman procedures were included within this m/z range. The lowest m/z within the range corresponds to a methyl modification and the highest m/z corresponds to a modification of 149 Da. To cover the whole m/z range and the four monitored fragments, each sample was injected 12 times. For each injection, transitions for acrylamide (AA) and glycidamide derivatives, commonly present as background adducts [36] , and corresponding deuterium-substituted internal standards, were included as reference compounds. The AA internal standard (AA-d 7 -Val-FTH) was used for semi-quantitative determination of adduct levels.
From the chromatograms, analytes qualifying as adduct candidates (compounds exhibiting at least two of the monitored fragments, as described above) were selected. These compounds were further studied in product ion scan mode and their fragmentation patterns compared with those of known adduct analytes. To control for possible artifactual formation of adducts or interfering compounds, control experiments were performed. In the control experiments, equine myoglobin and HSA (that do not have Val as the N-terminal amino acid) were derivatized and worked-up according to the FIRE procedure and analysed (targeted analysis) for the adduct candidates. Some preliminary adduct candidate compounds could be excluded after detection in the control samples. In total, 20 analytes, assumed to be unidentified adducts (unknowns), were detected, as well as the six previously known adducts mentioned above (corresponding to acrylamide, acrylonitrile, ethylene oxide, glycidamide, methylation and methyl vinyl ketone). Fourteen of the unknown adducts exhibited fragmentation patterns similar to those of previously studied Hb-Val adduct derivatives. The semi-quantitatively determined adduct levels are presented in an adductome map format in fig. 3 . As no large differences were observed for the unknown adducts when comparing smokers and non-smokers, the average adduct levels for all 12 samples are shown. Significantly higher levels of the previously known adducts from acrylamide, glycidamide, ethylene oxide and acrylonitrile were observed in the smoker samples, as expected from earlier studies [34, 36] . Adducts that were unidentified at the time of the screening, but have been identified in later studies are written out in the figure.
Application of the adductomic approach in larger sample series. After the first application of the adductomic approach described above, targeted screening of the detected adducts has been performed for larger sample sets in several so far unpublished studies. This was done to obtain a statistical basis for future studies and applications of the methodology. In total, approximately 250 samples from three collaborative projects have been analysed (with n = 50-120 for the separate sample sets). The majority of the previously detected adducts were detected in all analysed samples. Large interindividual differences in adduct levels were observed. What the large variations in adduct levels mean in the context of exposure and metabolism is so far unknown, but may be of importance for future studies. The repeatability of the approach is about 20% (relative standard deviation) for all adducts with mean adduct levels above 10 pmol/g Hb. 
Identification of Unknown Hb Adducts
A challenge following adductomic experiments is the identification of detected adducts. Ideally, the adductome data should provide some parameters useful for identification. From the screening of adducts described above, the information received for detected unknown adducts is the m/z of the precursor ions ([M + H] + ) and the retention times. Based on these two parameters, a strategy for identifying unknown Hb adducts was formulated and applied for identification of several of the previously detected adducts [21] . The strategy for identifying unknown adducts involves several steps, the first being the calculation of the mass of the Hb modifications by subtracting m/z 489 from the precursor ions. The m/z 489 fragment corresponds to the FTH derivative of unmodified Val ( fig. 1) . From the obtained masses, the corresponding precursor electrophiles may be suggested. Such compounds should normally be reactive with functional groups such as activated double bonds, aldehydes and epoxides (table 1). The process of suggesting probable adduct precursors may be facilitated by the use of databases. A useful database for this purpose is 'Search for Species Data by Molecular Weight' provided by the National Institute of Standards and Technology [37] . This system searches for species with molecular weights within 0.5 units of the input value, based on single isotope atomic masses.
Reversed-phase chromatography [Discovery HS C18 (3.0 lm, 2.1 mm 9 150 mm) with a corresponding guard column (Supelco Analytical, Bellefonte, PA, USA)] was used for the adductomic experiments, meaning that the retention times mainly correlate with the lipophilicities of the analytes. Previously identified adducts were included in the screening and used as reference points when matching retention times of unknowns with suggested adducts. The hypothesized adduct analytes, corresponding to suggested precursor electrophiles (suggested according to the criteria described above), were drawn in ChemBioDraw Ultra 12.0 (CambridgeSoft, Cambridge, MA, USA). The theoretical Log P of the analytes, given by the software, was compared with the theoretical Log P values of the previously known adducts to conclude whether the observed retention time of the unknown adduct could match that of the theoretical hypothesized analyte. The overall linear correlation between retention time and theoretical Log P is strong for the identified adducts (the coefficient of determination, R 2 , is 0.88), and with a few exceptions, the retention time can be suggested relatively well from the Log P value [21] .
To test the identity hypotheses, reference Hb adducts were generated by performing in vitro incubations with the suggested precursor electrophiles in human blood. Electrophiles were added to human blood at relatively high concentrations (125 lM-100 mM, depending on the reactivity of the electrophiles) to form adducts. The incubated blood was processed and analysed according to the FIRE procedure. The in vitrogenerated adducts, formed at high levels, were then compared with the unidentified adducts observed in untreated human blood samples, considering the precursor ions, retention times and fragmentation patterns in the LC-MS/MS analysis. An adduct was considered identified if those parameters were matching [21] .
Previously unknown N-terminal Hb adducts identified using adductome data. In the evaluation of the N-terminal Hb adductome data, we have identified six previously unknown adducts ( fig. 4) , individually presented below.
Ethyl adduct. After the first application of the method, an unknown adduct corresponding to the ethyl adduct was identified [22] . The reference adduct was generated by in vitro incubation of human blood with iodoethane. To our knowledge, the results from this screening were the first observation of ethyl adducts in human Hb. Ethyl adducts have previously been observed in DNA [38] , and a possible source to the adduct may be alcohol consumption. The adduct has been suggested to form from the in vivo reduction of the ethylidene adduct, which is the major adduct from acetaldehyde formed in the metabolism of ethanol [39] .
Ethyl vinyl ketone (pentyl-3-one) adduct. The second adduct to be identified was an adduct formed from the precursor electrophile ethyl vinyl ketone (EVK), an a, b-unsaturated ketone that forms adducts through Michael addition ( fig. 4 ) [40] . This adduct had previously not been reported in vivo. EVK is found as a naturally occurring and a synthetic flavouring substance in a wide range of foods and beverages (cf. [40] for a summary of occurrences of this compound). A major occurrence of EVK is in orange essence oil, commonly used in orange juice products [41] . The concentrations of EVK in individual food items are generally expected to be low, but the presence of EVK in a diversity of frequently consumed food items indicates a significant human exposure. Most probably, the diet is the major exposure source of observed EVK adducts, but the compound could possibly also be formed endogenously during metabolism and other cellular processes.
Adducts from glyoxal (carboxymethyl) and methylglyoxal (1-carboxyethyl) . Two of the identified adducts correspond to glyoxal and methylglyoxal ( fig. 4 ). These compounds are reactive aldehydes that are proposed to form adducts through Schiff base formation followed by Cannizzaro rearrangement [42] . Glyoxal and methylglyoxal are formed both in vitro and in vivo [43] as sugar fragmentation products, through oxidation of lipids and through degradation of Maillard reaction products. The major exposure source for human beings is food, and the concentrations are higher in sugar-rich foods. The corresponding adducts are examples of advanced glycation end products (AGEs). AGEs are considered to be of importance for complications of diabetes mellitus, ageing and oxidative stress [43] . The FIRE procedure could offer an alternative approach to measure these modifications in human beings. The Hb adduct corresponding to glyoxal, being a carboxymethylation of the N-terminal Val, is one of the most abundant adducts observed in most human blood samples ( fig. 3 ). This adduct has been shown to form in the degradation of glycated Hb, Hb1Ac [44] . As several per cent of the N-terminals in human Hb normally are glycated, this is believed to be the reason for the high adduct levels observed. Only a small fraction of the observed adduct levels is expected to originate from actual glyoxal exposure, which forms N-terminal Hb adducts at a relatively slow rate [21] .
Acrylic acid (2-carboxyethyl) adduct. Acrylic acid was identified as a precursor to one of the previously unknown adducts ( fig. 4 ). This compound is an a, b-unsaturated carboxylic acid and reacts with N-terminal Hb-Val through aza-Michael addition. This compound has been identified as a Maillard reaction product [45] and is mainly formed through degradation of aspartic acid, but also via thermolytic deamination of alanine [46] . Oxidation of acrolein, formed as a product of thermal degradation and/or oxidation of free fatty acids or glycerol, is another source of acrylic acid [47] . The main exposure source of acrylic acid is therefore expected to be from the diet. Exposure to acrylic acid from food is expected to be lower than 1 lg/kg body-weight and day [45] . Due to a pK a of 4.23, the deprotonated and inert form of acrylic acid (acrylate ion) will predominate at physiological pH values. The low toxicity observed of the compound, with no observed genotoxicity or carcinogenicity [45] , is believed to be due to the small fraction of the reactive form present in vivo. There may be other sources for the in vivo observed adduct; Wang et al. [48] suggested that endogenous nitrosation of dihydrouracil, an abundant metabolite formed from uracil, may be a likely major source for the same adduct (2-carboxyethyl) observed in DNA.
1-Octen-3-one (octyl-3-one) adduct. The sixth identified adduct corresponds to 1-octen-3-one, an a, b-unsaturated ketone that forms N-terminal Hb adducts through aza-Michael addition ( fig. 4) , which is the first observation of this adduct in vivo. 1-Octen-3-one has been reported as the main compound responsible for the typical metallic odour when metals or blood touch the skin [49] . The compound is formed as a degradative reduction product in the reaction of skin lipid peroxides with ferrous ions (Fe 2+ ) formed in the sweatmediated corrosion of iron. The suggested main exposure source of 1-octen-3-one in vivo is from endogenous decomposition of lipid peroxides. There are also exogenous exposure sources as the compound has been detected in different foods, for example dairy products, mushrooms, cooked meat and fresh fish (cf. [21] for full references).
Oxidative degradation of arachidonic acid has been suggested as a pathway for the formation of 1-octen-3-one in food [50] .
Evaluation of identified Hb adducts.
After the identification of adducts and tracing of their precursors, the next step is to evaluate their significance with regard to possible contributions to health risks. This may be done in several ways, for example by studies of toxicokinetics and genotoxic potency of the electrophilic precursors. For the adduct formed from ethyl vinyl ketone (EVK; cf. above), we did an extensive quantitative characterization of the adduct kinetics to estimate the daily internal dose (area under the concentration-time curve, AUC) of EVK in human beings [40] . This involved determination of the second-order reaction rate constant towards N-terminal Val in Hb and estimation of the stability (half-life) of the formed adducts. EVK was shown to form adducts at a high rate, being about 2 9 10 3 more reactive than the reference compound acrylamide. The N-terminal EVK adduct was also shown to be unstable, with a half-life of 7.6 hr, which is very short compared to other studied Hb adducts. The daily AUC in human beings of EVK was estimated to be about 20 times lower than the corresponding AUC of acrylamide from intake via food. This quantitative evaluation illustrates the first steps in the evaluation of the significance of an adduct detected through adductomics.
Future Perspectives
It is now 10 years since the adductome concept was introduced by Kanaly et al. [12] . Since then, the potential of adductomic approaches has been clearly demonstrated in several key publications. During this early-phase, much focus has been on method development, and only a few studies involving sample series >10 samples (table 2) have been reported. For adductomics to reach its full potential, it is necessary that the methodology is applied on a larger scale, and that continued efforts are done to identify adducts and track their probable precursors.
Several research groups have already applied high-resolution mass spectrometry [18] [19] [20] for adductomics, which should facilitate the process of identifying unknown adducts. We are presently working with the adaption of the FIRE procedure for HRMS, using an Orbitrap-type mass spectrometer. There is also a need for software for convenient evaluation of adductome data. Grigoryan et al. [16] have recently described an 'adductomics pipeline' in which specifically written software is used to select adducts based on mass spectra (selecting ions displaying a number of characteristic fragments as adduct candidates). Such software could greatly facilitate the timedemanding evaluation of adductome data and allow evaluation of large sample series. Currently, there is no suitable commercial software that could be used for such tasks.
To assess the whole adductome, different methodologies and approaches are needed in conjugation. By screening several nucleophilic targets, a larger range of adducts will be observed. There are presently suitable methods available to screen for adducts to DNA, Cys34 in HSA and N-terminal Val in Hb. These methods are complementary and if used in parallel should result in a greater insight into the adductome. Concerning Hb adducts, it would be valuable to compare adduct profiles at multiple nucleophilic sites within Hb and to apply alternative methods to cover more adducts (e.g. ringclosed adducts which are not applicable for the FIRE procedure). Goel et al. [51] have reported a promising method for untargeted analysis of adduct-containing tryptic peptides from Hb that potentially could be used for adductomics. Chen et al. [52] have developed a sensitive assay for simultaneous analysis of several post-translational modifications of Hb in human blood samples by nanoflow LC-MS/MS requiring only 10 lL blood. This assay was recently used to measure the extent of chlorination, nitration and oxidation at 12 different sites in Hb (including tyrosine, methionine and cysteine residues) in blood samples from patients with type 2 diabetes mellitus [53] . This is a good example of a how modifications at different sites within proteins may be studied, and the methodology could potentially be used for adductomics.
After identification of previously unknown adducts, a large range of follow-up studies may be relevant, as exemplified with the great number of studies after the detection of the acrylamide adduct in human blood [33] . To assess the possible contribution to health risks from the identified precursor electrophiles, studies of toxicokinetics and genotoxic potency will be relevant.
Conclusions
Adductomic approaches are powerful as they may greatly expand the number of adducts observed compared to targeted approaches. The strengths of adductomics are illustrated by our work concerning Hb adducts. The adductome is still largely unexplored, and with the increasing sensitivity of new mass spectrometers and new methodologies, many unknown adducts will likely be detected in the upcoming years. A large challenge after adductomic experiments is the identification of detected unknown adducts. The strategy used for the identification of unknown adducts described in this MiniReview could also be useful for studies of other adductomes. The adducts identified in our work will be further investigated to explore their potential as biomarkers for exposure. The possibilities of adductomics have not been fully explored, and the methodology could potentially be used for many different applications. Adductomic approaches are expected to be useful in characterization of the exposome.
